{"gene":"NFE2L1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1989,"finding":"NRF-1 (NFE2L1) was identified as a sequence-specific transcriptional activator binding to a recognition element in the rat somatic cytochrome c promoter; mutational analysis showed the NRF-1 site is required for maximal cytochrome c promoter activity, and the factor makes specific guanine nucleotide contacts within its recognition sequence.","method":"Promoter mutational analysis, DNA-binding/competition assays, in vivo transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding, mutagenesis, and in vivo promoter assays; foundational paper replicated by multiple subsequent studies","pmids":["2547796"],"is_preprint":false},{"year":1990,"finding":"NRF-1 functions as a trans-activator of multiple nuclear-encoded respiratory genes (cytochrome c, cytochrome oxidase subunit VIc, ubiquinone-binding protein of reductase complex, MRP RNA gene); NRF-1-binding activities for each site copurify chromatographically, have the same thermal lability, and make similar guanine nucleotide contacts, indicating a single factor recognizes all sites; in vitro recognition correlates with in vivo transcriptional activation.","method":"DNA competition binding assays, chromatographic copurification, methylation interference footprinting, in vivo transfection assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods (copurification, footprinting, in vivo assays) with multiple target genes","pmids":["2166701"],"is_preprint":false},{"year":1992,"finding":"NRF-1 directly binds and activates functional recognition sites in the ATP synthase γ-subunit gene (complex V), eukaryotic initiation factor 2α gene, and tyrosine aminotransferase gene; the binding activities for all sites copurify ~33,000-fold and reside in a single 68-kDa protein.","method":"Competition binding assays, methylation interference footprinting, UV-induced DNA cross-linking, chromatographic copurification, transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods, purification to single protein, in vivo confirmation","pmids":["1348057"],"is_preprint":false},{"year":1993,"finding":"The NRF-1 DNA-binding domain was mapped to the amino-terminal half of the protein by deletion analysis; cloning revealed NRF-1 defines a new class of DNA-binding proteins sharing sequence identity with sea urchin P3A2 and Drosophila EWG; recombinant NRF-1 reproduced the DNA-binding specificity and transcriptional activation of authentic HeLa NRF-1.","method":"cDNA cloning from HeLa cells using tryptic peptide sequences, deletion mapping, recombinant protein production, transcription activation assays, antiserum supershift","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — cDNA cloning with biochemical validation, deletion mapping of functional domain, multiple orthogonal methods in one study","pmids":["8253388"],"is_preprint":false},{"year":1996,"finding":"TCF11/NFE2L1 forms heterodimers with small Maf proteins (MafG, MafK); heterodimerization with small Maf proteins alters DNA-binding characteristics of TCF11, producing stronger binding to NF-E2 sites than TCF11 alone; TCF11 isoforms bound to NF-E2 sites were detected in K562 erythroid cell nuclear extracts by antibody supershift.","method":"In vitro heterodimerization assays, EMSA/supershift assays, antibody detection in nuclear extracts","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding assays plus in-cell nuclear extract confirmation, replicated in follow-up paper (PMID:9421508)","pmids":["8932385"],"is_preprint":false},{"year":1997,"finding":"LCR-F1/NFE2L1 is essential for gastrulation in mice; homozygous null embryos fail to form a primitive streak and lack detectable mesoderm, demonstrating a non-cell-autonomous role; LCR-F1 null ES cells contribute normally to mesodermally derived tissues including erythroid cells in chimeras, indicating the function is mediated through signaling molecules rather than cell-intrinsic globin gene regulation.","method":"Gene targeting/knockout in mouse ES cells, blastocyst injection chimeras, developmental phenotype analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined developmental phenotype, epistasis established via chimera rescue","pmids":["9087432"],"is_preprint":false},{"year":1998,"finding":"TCF11/NFE2L1 and MafG form a heterodimer that preferentially recognizes the NF-E2/antioxidant response element (ARE) sequence 5'-TGCTgaGTCAT-3'; MafG alone acts as a transcriptional repressor, while TCF11 alone activates transcription; when co-expressed, MafG inhibits TCF11 transactivation in a dose-dependent manner despite the higher DNA affinity of the heterodimer.","method":"Binding-site selection assay (SELEX), transient transfection reporter assays, in vitro dimerization assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — SELEX for binding-site definition plus functional reporter assays, single lab but multiple methods","pmids":["9421508"],"is_preprint":false},{"year":1998,"finding":"Homozygous disruption of Nrf1/NFE2L1 in mice causes anemia due to a non-cell-autonomous defect in definitive erythropoiesis and embryonic lethality in utero.","method":"Targeted gene disruption in mice (knockout), histological and hematological analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype; independently consistent with LCR-F1 KO paper (PMID:9087432)","pmids":["9501099"],"is_preprint":false},{"year":1998,"finding":"NRF-1 binding sites in both human TFB1M and TFB2M (mitochondrial transcription specificity factor) promoters are required for maximal trans-activation by PGC-1α and PRC coactivators; ectopic expression of PGC-1α induces TFB1M, TFB2M, and Tfam coordinately along with NRF-1 target respiratory subunits.","method":"Promoter mutational analysis, transient transfection reporter assays, ectopic expression of PGC-1α","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — NRF-1 site mutagenesis plus ectopic coactivator expression; independently validated by PGC-1β study (PMID:20561910)","pmids":["15684387"],"is_preprint":false},{"year":2000,"finding":"NRF-1 is phosphorylated sequentially after serum stimulation, and this phosphorylation increases its trans-activation activity on the cytochrome c promoter, leading to enhanced mitochondrial respiration; both NRF-1 and CREB binding sites contribute equally to serum-induced cytochrome c expression.","method":"Promoter mutant transfections, phosphorylation analysis, mitochondrial respiration measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods in one lab (promoter mutants + phosphorylation assays + respiration), single lab","pmids":["10777619"],"is_preprint":false},{"year":2000,"finding":"Dynein light chain physically interacts with NRF-1, requiring the first 26 amino acids of NRF-1; interaction was confirmed by yeast two-hybrid screening, chemical crosslinking of purified native proteins, and co-immunoprecipitation from mammalian cells; both NRF-1 and dynein light chain display similar nuclear staining patterns. The same interaction is conserved with Drosophila EWG, which also binds and trans-activates through NRF-1 binding sites.","method":"Yeast two-hybrid screening, chemical crosslinking of purified proteins, co-immunoprecipitation, immunolocalization/confocal microscopy, transcription assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Y2H + crosslinking of purified proteins + co-IP + immunolocalization) in one study","pmids":["11069771"],"is_preprint":false},{"year":2000,"finding":"NRF-1 (alpha-Pal/Nrf-1) binds the FMR1 promoter in brain and testis extracts; methylation of the NRF-1 site abolishes NRF-1 binding to the FMR1 promoter, suggesting that DNA methylation silences FMR1 in part by blocking NRF-1 access.","method":"EMSA with nuclear extracts, transcription factor binding-site analysis, methylation interference","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus methylation-blocking experiment, single lab","pmids":["11058604"],"is_preprint":false},{"year":2001,"finding":"TCF11/NFE2L1 transactivates the GCS heavy subunit (GCS-h) promoter through antioxidant response elements (AREs), with EMSA showing TCF11 binds one specific ARE as a heterodimer with small Maf proteins; TCF11 overexpression increases intracellular glutathione levels in COS-1 cells.","method":"Overexpression in COS-1 cells, co-transfection reporter assays, EMSA, glutathione measurement","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with deletion/mutation plus EMSA and cellular phenotype, single lab","pmids":["11342101"],"is_preprint":false},{"year":2001,"finding":"Full-length TCF11 requires two separate transactivation domains (an N-terminal acidic domain and a serine-rich stretch adjacent to the CNC-bZIP domains) for transcriptional activity; the shorter LCR-F1 isoform lacks transactivation ability but can act as a dominant-negative inhibitor of the full-length form, providing an isoform-based regulatory mechanism.","method":"Domain deletion/swapping mutants, transient transfection reporter assays in multiple cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic deletion/swap mutagenesis with reporter assays, single lab","pmids":["11278371"],"is_preprint":false},{"year":2003,"finding":"c-Myc directly activates cytochrome c gene expression through NRF-1 target sites; NRF-1 overexpression sensitizes cells to apoptosis on serum depletion; dominant-negative NRF-1 prevents c-Myc-induced apoptosis without affecting c-Myc-dependent proliferation, placing NRF-1 downstream of c-Myc specifically in the apoptotic branch.","method":"Northern analysis, transactivation assays, in vitro and in vivo promoter binding assays, dominant-negative NRF-1 expression, apoptosis assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods including dominant-negative epistasis, in vitro and in vivo promoter binding, and functional cell death assays","pmids":["12533512"],"is_preprint":false},{"year":2003,"finding":"TCF11/NFE2L1 is exported from the nucleus via a nuclear export signal (NES) in its N-terminus through the CRM1/exportin pathway; the full-length form is both cytoplasmic and nuclear, while the shorter internally initiated isoform is restricted to the nucleus; mutating three leucine residues in the NES largely blocks export. Alternative-splicing isoforms lacking the NES are constitutively nuclear.","method":"Cellular fractionation, immunofluorescence localization, leptomycin B treatment, NES mutagenesis","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization experiments with pharmacological and mutagenesis confirmation, functional consequence (isoform nuclear restriction) defined","pmids":["12729924"],"is_preprint":false},{"year":2004,"finding":"NRF-1 (alpha-Pal/NRF-1) occupies the FMR1 promoter in vivo (chromatin immunoprecipitation); NRF-1 and Sp1 synergistically activate FMR1 transcription; NRF-1 transactivation is sensitive to dense CpG methylation of the promoter; siRNA knockdown of endogenous NRF-1 reduces FMR1 reporter activity in HeLa cells.","method":"Chromatin immunoprecipitation (ChIP), transient transfection reporter assays, siRNA knockdown, methylation sensitivity assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo ChIP plus siRNA knockdown with functional readout and methylation-sensitivity experiments, multiple orthogonal methods","pmids":["15175277"],"is_preprint":false},{"year":2006,"finding":"PRC (PGC-1-related coactivator) physically binds NRF-1 in vitro and forms a complex with NRF-1 in cell extracts; CREB also binds PRC at overlapping sites; a CREB/NRF-1 interaction domain on PRC is required for transactivation of the cytochrome c promoter; PRC occupies the cytochrome c promoter in vivo and its occupancy is elevated upon serum induction.","method":"In vitro binding assays, co-immunoprecipitation from cell extracts, chromatin immunoprecipitation, dominant-negative lentivirus expression, respiratory growth assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus in vitro binding plus ChIP plus functional respiratory growth assay, multiple orthogonal methods","pmids":["16908542"],"is_preprint":false},{"year":2007,"finding":"TCF11/MafG heterodimer binds an element in the iNOS promoter (identified by ChIP and mutation analyses) and represses iNOS induction; TGF-β1 induces TCF11/MafG binding to this site via a protein kinase C-dependent mechanism; siRNA knockdown of TCF11 blocks TGF-β-mediated suppression of iNOS.","method":"Chromatin immunoprecipitation, promoter mutation analysis, siRNA knockdown, PKC inhibitor studies, in vivo rat endotoxemia model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, mutagenesis, siRNA, pharmacological inhibition, and in vivo model; multiple orthogonal methods","pmids":["17928287"],"is_preprint":false},{"year":2009,"finding":"NRF-1 directly interacts with PARP-1 and co-purifies a PARP-1·DNA-PK·Ku80·Ku70·topoisomerase IIβ-containing complex; the DNA-binding/dimerization domain of NRF-1 and the N-terminal zinc finger/auto-modification domain of PARP-1 mediate the interaction; DNA-bound NRF-1 can recruit this complex to promoters; PARP-1 can PARylate the DNA-binding domain of NRF-1 and negatively regulate the NRF-1·PARP-1 interaction.","method":"In vitro binding assays, co-purification, domain mapping, PARylation assay, ChIP, transient transfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro biochemical reconstitution, domain mapping, PARylation assay, and in-cell ChIP; multiple orthogonal methods","pmids":["19181665"],"is_preprint":false},{"year":2010,"finding":"TCF11 (long isoform of NFE2L1) is identified as the key transcription factor driving 26S proteasome gene expression in response to proteasome inhibition (bounce-back response). Under basal conditions, TCF11 resides in the ER membrane and is targeted to ER-associated degradation (ERAD) requiring E3 ubiquitin ligase HRD1 and AAA-ATPase p97; proteasome inhibition promotes nuclear translocation of TCF11, where it binds antioxidant response elements (AREs) in proteasome gene promoters.","method":"Transcription factor identification by cell-based assays, subcellular fractionation, dominant-negative ERAD component expression, promoter-binding assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — identification of ERAD-dependent regulatory mechanism with multiple genetic and biochemical tools, published in high-impact journal; foundational paper replicated by multiple labs","pmids":["20932482"],"is_preprint":false},{"year":2013,"finding":"Sox9 directly regulates Nfe2l1 expression in gliogenic radial glia; Nfe2l1 promotes glial fate under direct Sox9 regulatory control in developing spinal cord.","method":"Gene expression profiling, chromatin immunoprecipitation, functional assays in developing CNS","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct Sox9-Nfe2l1 interaction plus functional glial-fate assay, single lab","pmids":["23840004"],"is_preprint":false},{"year":2014,"finding":"PARK2/Parkin-mediated mitophagy is required for NFE2L1 nuclear translocation and subsequent proteasome activation during denervation-induced muscle atrophy; in both autophagy-deficient and Park2-knockout muscles, NFE2L1 nuclear translocation was absent and proteasome activation failed, while polyubiquitinated proteins accumulated.","method":"Autophagy-deficient and Park2-knockout mouse models, denervation atrophy model, subcellular fractionation, proteasome activity assays","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function models with defined molecular phenotype (nuclear translocation failure) and functional consequence (proteasome activation deficit)","pmids":["24451648"],"is_preprint":false},{"year":2018,"finding":"NFE2L1 undergoes multi-step post-translational processing: the nascent polypeptide is transiently translocated into the ER lumen and becomes an inactive glycoprotein (glycosylation by OST); it is then retrotranslocated by p97; deglycosylated by glycosidases to yield a deglycoprotein; and proteolytically processed by cytosolic DDI-1/2 and proteasomes to generate N-terminally truncated active isoforms. Coupled positive and negative feedback circuits exist between NFE2L1 and its regulators (p97, Hrd1, DDI-1, proteasomes).","method":"Cell-based mutagenesis, glycosylation/deglycosylation assays, pharmacological inhibitors of p97/ERAD, proteasome inhibitors, western blot isoform analysis","journal":"Toxicology and applied pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical and genetic approaches mapping sequential PTM steps and feedback circuitry; consistent with other ERAD processing papers","pmids":["30287392"],"is_preprint":false},{"year":2020,"finding":"NFE2L1 and NFE2L3 complementarily maintain basal proteasome activity in cancer cells; double knockdown of NFE2L1 and NFE2L3 impairs basal proteasome activity and reduces expression of seven proteasome-related genes; NFE2L3 represses NFE2L1 translation via induction of CPEB3, which binds the NFE2L1 3' UTR and decreases polysome formation on NFE2L1 mRNA.","method":"Double siRNA knockdown, proteasome activity assays, mRNA polysome analysis, CPEB3 binding assays, gene expression analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double KD with specific proteasome activity readout plus translational repression mechanism (polysome analysis + 3' UTR binding), multiple orthogonal methods","pmids":["32366381"],"is_preprint":false},{"year":2022,"finding":"NFE2L1 promotes ferroptosis resistance independent of NFE2L2 by maintaining expression of glutathione peroxidase 4 (GPX4), a key inhibitor of lethal lipid peroxidation; NFE2L2 promotes ferroptosis resistance through a distinct mechanism that appears independent of GPX4 protein expression.","method":"NFE2L1/NFE2L2 gene knockout cellular models, ferroptosis induction assays, GPX4 expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with specific ferroptosis assay, mechanistic separation of NFE2L1 vs NFE2L2 via GPX4 expression, multiple cell systems","pmids":["35271393"],"is_preprint":false},{"year":2022,"finding":"NFE2L1 loss reduces cellular viability after ferroptosis induction; NFE2L1 protects from ferroptosis by sustaining proteasomal activity; Gpx4-deficient mice show reduced proteasomal activity associated with ferroptosis; Nfe2l1-deficient mice show brown adipose tissue involution, hyperubiquitination of ferroptosis regulators including the GPX4 pathway, and other ferroptosis hallmarks.","method":"NFE2L1 loss-of-function in cellular systems and mouse models (Gpx4-KO, Nfe2l1-deficient), proteasome activity assays, patient-derived cell line with GPX4 mutation","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (cell lines, patient cells, Gpx4-KO mice, Nfe2l1-deficient mice) with proteasome and ferroptosis assays","pmids":["34999280"],"is_preprint":false},{"year":2022,"finding":"Glycosylation of NFE2L1 enables it to sense the energy state; loss of NFE2L1 in hepatocytes leads to lethality upon glucose deprivation and affects glucose uptake; NFE2L1 directly interacts with and inhibits AMPK (demonstrated by co-expression and co-immunoprecipitation), placing NFE2L1 as a negative regulator of AMPK signaling.","method":"NFE2L1 silencing in HepG2 cells, glucose deprivation assays, co-immunoprecipitation, transcriptome and metabolome analysis, Seahorse assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating direct NFE2L1-AMPK interaction, single lab, supported by functional readouts","pmids":["35614059"],"is_preprint":false},{"year":2023,"finding":"NRF1/NFE2L1 transcriptionally induces p62/SQSTM1 and GABARAPL1 (an ATG8 family gene) after proteasome inhibition, activating aggrephagy; NRF1 is required for formation of p62-positive puncta, their colocalization with ULK1 and TBK1, and Ser403 phosphorylation of p62; NRF1 thus couples the proteasome bounce-back response to selective autophagy.","method":"Genome-wide transcriptome analysis (RNA-seq), NRF1 knockdown, immunofluorescence, co-immunoprecipitation, phosphorylation assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide target identification plus multiple functional validation methods (KD, immunofluorescence, phosphorylation assay); novel mechanism orthogonal to prior proteasome findings","pmids":["37658135"],"is_preprint":false},{"year":2024,"finding":"SCFFBS2 (an N-glycan-recognizing E3 ligase) cooperates with the RBR-type E3 ligase ARIH1 to ubiquitinate NFE2L1 through oxyester bonds at N-GlcNAc residues (generated by ENGASE from N-glycans); this non-canonical ubiquitination assembles atypical ubiquitin chains (requiring UBE2L3) and inhibits DDI2-mediated proteolytic activation of NFE2L1. The polyubiquitination was biochemically reconstituted on glycopeptides.","method":"In vitro reconstitution of polyubiquitination on glycopeptides, identification of SCFFBS2-ARIH1 E3 complex, ENGASE activity assay, mass spectrometry of ubiquitination sites, cell-based NFE2L1 activation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution of ubiquitination on glycopeptides plus identification of E3 complex and UBE2 requirement plus cell-based functional consequence; rigorous multi-method study","pmids":["39116872"],"is_preprint":false},{"year":2024,"finding":"DDI2 protease-mediated proteolytic cleavage of NFE2L1 is a critical step for ferroptosis-induced feedback activation of proteasome function; cells lacking DDI2 cannot activate NFE2L1 in response to RSL3 and show global hyperubiquitylation; ferroptosis induction leads to proteasome inhibition that activates NFE2L1 through DDI2 cleavage.","method":"DDI2 genetic disruption, proteomic ubiquitylation site mapping, RSL3-induced ferroptosis, proteasome activity assays, nelfinavir (DDI2 inhibitor) treatment","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic DDI2 KO, unbiased proteomic approach plus pharmacological inhibition and functional proteasome/cell death assays; multiple orthogonal methods","pmids":["39384955"],"is_preprint":false},{"year":2020,"finding":"Nelfinavir inhibits the TCF11/Nrf1-driven proteasome recovery pathway by dual mechanism: decreasing total TCF11/Nrf1 protein level and inhibiting its DDI2-mediated proteolytic processing, thereby reducing nuclear TCF11/Nrf1 and proteasome gene re-synthesis.","method":"TCF11/Nrf1 protein level and nuclear fraction analysis, proteasome gene expression assays, DDI2 inhibition in multiple myeloma cells","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic drug-target study with protein level and processing assays, single lab","pmids":["32344880"],"is_preprint":false},{"year":2021,"finding":"NFE2L1 regulates osteoclast differentiation in an isoform-specific manner: long isoforms of NFE2L1 accelerate Nfatc1/α induction and antioxidant gene expression, while the short isoform NFE2L1-453 suppresses these effects; myeloid-specific Nfe2l1 knockout mice show increased osteoclast activity, decreased bone mass, and worsened osteoporosis. NFE2L1 deficiency leads to enhanced ROS accumulation in early osteoclastogenesis.","method":"Myeloid-specific conditional KO (LysM-Cre), ovariectomy and aging models, bone marrow cell and RAW 264.7 cell differentiation assays, isoform-specific knockdown","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with specific bone phenotype plus mechanistic isoform dissection and multiple in vitro/in vivo models","pmids":["34763297"],"is_preprint":false},{"year":2018,"finding":"Adipocyte-specific Nfe2l1 knockout mice exhibit reduced subcutaneous adipose tissue mass, insulin resistance, adipocyte hypertrophy, and severe adipose inflammation; mechanistic studies revealed Nfe2l1 deficiency disturbs expression of lipolytic genes in adipocytes, leading to adipocyte hypertrophy followed by inflammation and pyroptosis.","method":"Adipocyte-specific conditional KO (Nfe2l1(f)-KO), metabolic phenotyping, gene expression analysis of lipolytic genes","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean conditional KO with defined metabolic phenotype, mechanistic link to lipolytic gene expression, single lab","pmids":["29935181"],"is_preprint":false},{"year":2010,"finding":"PGC-1β promotes mitochondrial biogenesis and function in myotubes through direct interaction with NRF-1 and ERRα; deletion or mutation of NRF-1 and/or ERRα binding sites in target gene promoters attenuates PGC-1β-mediated activation; siRNA inhibition of NRF-1 or ERRα abolishes the mitochondrial biogenesis function of PGC-1β.","method":"Overexpression, siRNA knockdown, promoter deletion/mutation reporter assays, co-immunoprecipitation","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction confirmed by Co-IP, promoter mutagenesis, and siRNA functional assays; single lab","pmids":["20561910"],"is_preprint":false},{"year":2017,"finding":"HTLV-1 bZIP factor (HBZ) physically interacts with NRF-1 and inhibits NRF-1's DNA-binding ability, thereby suppressing NRF-1-dependent TDP1 gene transcription; this mechanism underlies reduced TDP1 in adult T-cell leukemia cells, making them susceptible to abacavir.","method":"Co-immunoprecipitation of HBZ and NRF-1, dominant-negative NRF-1, luciferase reporter assays, shNRF-1 knockdown","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating physical interaction plus functional reporter and knockdown assays, single lab","pmids":["28993637"],"is_preprint":false},{"year":2023,"finding":"NFE2L1 overexpression stimulates proteasome biogenesis and activity in retinal neurons and delays photoreceptor neuron loss in a preclinical mouse model of human blindness caused by misfolded proteins, demonstrating that a transcription-driven increase in the proteasome pool can enhance proteolytic capacity and confer neuroprotection.","method":"Nfe2l1 adeno-associated virus overexpression in mouse retina, proteasome activity assays, ubiquitin-proteasomal reporter clearance assay, photoreceptor neuron survival analysis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain-of-function with functional proteasome and neurodegeneration readouts, multiple assays","pmids":["37450596"],"is_preprint":false}],"current_model":"NFE2L1 (NRF-1/TCF11/LCR-F1) is a CNC-bZIP transcription factor that resides in the ER membrane under basal conditions, where it is glycosylated, ubiquitinated (via SCFFBS2-ARIH1 through non-canonical oxyester bonds on N-GlcNAc residues), and degraded by ERAD (requiring HRD1 and p97); upon proteasome inhibition or ferroptosis, it is retrotranslocated by p97, deglycosylated, proteolytically cleaved by DDI2, and translocated to the nucleus where it binds AREs to transcriptionally upregulate proteasome subunit genes (bounce-back response), aggrephagy mediators (p62/SQSTM1, GABARAPL1), and antioxidant genes including GCS-h and GPX4; in its role as a master regulator of nuclear-mitochondrial interactions, NRF-1 also directly activates nuclear-encoded respiratory chain subunits, mitochondrial transcription factors (Tfam, TFB1M, TFB2M), and numerous housekeeping genes, and is coactivated by PGC-1 family members (PGC-1α, PGC-1β, PRC) that bind NRF-1 directly; phosphorylation of NRF-1 by serum-stimulated kinases enhances its transactivation; it heterodimerizes with small Maf proteins (MafG/K), which modulate its DNA-binding affinity and can suppress its transactivation; it also interacts with dynein light chain (via its first 26 amino acids), PARP-1 (via its DNA-binding domain), and AMPK (directly inhibiting AMPK signaling); isoform-specific functions are established, with long isoforms (TCF11) acting as transcriptional activators and the short LCR-F1 isoform serving as a dominant-negative regulator."},"narrative":{"mechanistic_narrative":"NFE2L1 (NRF-1/TCF11/LCR-F1) is a CNC-bZIP transcription factor that serves dual master-regulatory roles in mitochondrial biogenesis and proteostasis [PMID:2166701, PMID:20932482]. It was first defined as a sequence-specific activator of nuclear-encoded respiratory genes, binding recognition elements through specific guanine contacts and trans-activating cytochrome c, cytochrome oxidase subunit VIc, ATP synthase γ-subunit, and other respiratory and housekeeping genes via a single ~68-kDa factor [PMID:2547796, PMID:2166701, PMID:1348057]; its DNA-binding domain lies in the amino-terminal half [PMID:8253388]. NRF-1 directly drives the mitochondrial transcription machinery, with NRF-1 sites in the Tfam, TFB1M, and TFB2M promoters required for coactivation by PGC-1 family members (PGC-1α, PGC-1β, PRC) that bind NRF-1 directly, integrating it into the program of mitochondrial biogenesis [PMID:15684387, PMID:16908542, PMID:20561910]; serum-stimulated phosphorylation enhances its transactivation and respiratory output [PMID:10777619]. The protein heterodimerizes with small Maf proteins (MafG/MafK), which increase its affinity for NF-E2/ARE sites yet can repress its transactivation, enabling combinatorial control of antioxidant and target genes such as the glutathione-synthesis gene GCS-h [PMID:8932385, PMID:9421508, PMID:11342101]. As a proteostatic regulator, NFE2L1 is synthesized into the ER membrane and constitutively targeted to ERAD, then retrotranslocated by p97, deglycosylated, and proteolytically processed by DDI-1/2 to generate active nuclear isoforms; upon proteasome inhibition it accumulates in the nucleus and binds AREs in proteasome subunit gene promoters to mount the proteasome bounce-back response [PMID:20932482, PMID:30287392, PMID:39384955]. This non-canonical activation is restrained by SCFFBS2–ARIH1, which ubiquitinates NFE2L1 through oxyester bonds on N-GlcNAc residues to block DDI2-mediated processing [PMID:39116872]. Beyond proteasome subunits, NFE2L1 couples this response to aggrephagy by inducing p62/SQSTM1 and GABARAPL1 [PMID:37658135] and protects against ferroptosis by sustaining GPX4 expression and proteasomal activity [PMID:35271393, PMID:34999280]. Isoform-specific control is intrinsic to the locus: long isoforms (TCF11) act as transcriptional activators, while the short LCR-F1 isoform lacks transactivation domains and behaves as a dominant-negative inhibitor [PMID:11278371]. Genetic studies establish essential physiological roles, with Nfe2l1 loss causing gastrulation failure and defective definitive erythropoiesis in mice and tissue-specific phenotypes in adipose, bone, and muscle [PMID:9087432, PMID:9501099, PMID:34763297, PMID:29935181].","teleology":[{"year":1990,"claim":"Established NRF-1 as a single trans-acting factor coordinating multiple nuclear-encoded respiratory genes, defining its core role in mitochondrial gene expression.","evidence":"DNA competition binding, chromatographic copurification, methylation interference footprinting, and in vivo transfection across cytochrome c, COX VIc, reductase, and MRP RNA genes","pmids":["2547796","2166701"],"confidence":"High","gaps":["Did not identify coactivators or upstream signals","Protein identity not yet cloned"]},{"year":1993,"claim":"Cloning and domain mapping defined NRF-1 as a new class of DNA-binding protein and localized its DNA-binding activity to the N-terminal half, enabling molecular dissection.","evidence":"cDNA cloning from HeLa tryptic peptides, deletion mapping, recombinant protein, supershift","pmids":["8253388"],"confidence":"High","gaps":["Transactivation domain architecture not yet mapped","Regulation of activity unknown"]},{"year":1998,"claim":"Showed NFE2L1 partners with small Maf proteins at NF-E2/ARE sites and that dimer composition tunes both DNA affinity and transactivation, revealing combinatorial regulation.","evidence":"In vitro heterodimerization, EMSA/supershift, SELEX, and reporter assays with MafG","pmids":["8932385","9421508"],"confidence":"High","gaps":["Cellular context determining activation versus repression unclear","ARE target gene repertoire not defined"]},{"year":1998,"claim":"Knockout mice established NFE2L1 as developmentally essential, required non-cell-autonomously for gastrulation and definitive erythropoiesis.","evidence":"Gene targeting, blastocyst chimeras, and developmental/hematological phenotyping in mice","pmids":["9087432","9501099"],"confidence":"High","gaps":["The signaling molecules mediating the non-cell-autonomous effect not identified","Direct target genes underlying the phenotype unknown"]},{"year":2001,"claim":"Defined isoform-based regulation: full-length TCF11 carries two transactivation domains while the short LCR-F1 isoform is a dominant-negative inhibitor.","evidence":"Domain deletion/swap mutants and reporter assays across cell lines; antioxidant GCS-h promoter activation via ARE","pmids":["11278371","11342101"],"confidence":"Medium","gaps":["Physiological balance of isoforms in tissues not measured","Mechanism of dominant-negative action not resolved"]},{"year":2006,"claim":"Linked NRF-1 to the PGC-1/PRC coactivator program and the mitochondrial transcription machinery, positioning it as an integrator of biogenesis signals.","evidence":"NRF-1 site mutagenesis in Tfam/TFB1M/TFB2M promoters, ectopic PGC-1α expression, reciprocal Co-IP, ChIP, and respiratory growth assays for PRC; serum-induced phosphorylation","pmids":["15684387","16908542","10777619","20561910"],"confidence":"High","gaps":["Kinases phosphorylating NRF-1 not identified","Structural basis of coactivator binding unknown"]},{"year":2009,"claim":"Identified physical partners beyond transcription, including dynein light chain and a PARP-1·DNA-PK·Ku·topoisomerase IIβ complex that NRF-1 can recruit and that PARylates its DNA-binding domain.","evidence":"Yeast two-hybrid, crosslinking of purified proteins, Co-IP, domain mapping, PARylation assay, and ChIP","pmids":["11069771","19181665"],"confidence":"High","gaps":["Functional consequence of dynein interaction for NRF-1 trafficking unclear","Genome-wide impact of PARP-1 recruitment not defined"]},{"year":2010,"claim":"Revealed NFE2L1 as the transcription factor driving the proteasome bounce-back response, controlled by ER residence and ERAD requiring HRD1 and p97.","evidence":"Cell-based factor identification, subcellular fractionation, dominant-negative ERAD components, and promoter-binding assays after proteasome inhibition","pmids":["20932482"],"confidence":"High","gaps":["Protease generating the active form not yet identified","Retrotranslocation-to-nucleus steps not fully ordered"]},{"year":2018,"claim":"Resolved the sequential post-translational processing pathway converting ER-bound glycoprotein NFE2L1 into active nuclear isoforms via p97 retrotranslocation, deglycosylation, and DDI-1/2 cleavage.","evidence":"Mutagenesis, glycosylation/deglycosylation assays, p97/ERAD and proteasome inhibitors, isoform western blots","pmids":["30287392"],"confidence":"High","gaps":["Quantitative feedback dynamics not modeled","Glycosidase identities incompletely defined"]},{"year":2023,"claim":"Extended NFE2L1's proteostatic output to selective autophagy and demonstrated therapeutic gain-of-function, coupling the bounce-back response to aggrephagy and neuroprotection.","evidence":"RNA-seq, knockdown, immunofluorescence of p62/ULK1/TBK1 puncta and Ser403 phosphorylation; AAV overexpression in mouse retina with proteasome and survival readouts","pmids":["37658135","37450596"],"confidence":"High","gaps":["Direct versus indirect induction of autophagy genes not fully separated","Durability of neuroprotective effect not established"]},{"year":2022,"claim":"Established NFE2L1 as a ferroptosis-resistance factor acting through GPX4 maintenance and proteasomal capacity, distinct from NFE2L2.","evidence":"Gene knockout cell and mouse models (Gpx4-KO, Nfe2l1-deficient), ferroptosis induction, GPX4 and proteasome activity assays, patient-derived cells","pmids":["35271393","34999280"],"confidence":"High","gaps":["Whether GPX4 is a direct transcriptional target not resolved","Tissue specificity of ferroptosis protection incompletely mapped"]},{"year":2024,"claim":"Defined the non-canonical ubiquitin switch and proteolytic activation controlling NFE2L1: SCFFBS2–ARIH1 ubiquitinates N-GlcNAc residues to block activation, while DDI2 cleavage activates the factor during ferroptosis-induced proteasome stress.","evidence":"In vitro reconstitution on glycopeptides, E3/UBE2L3 identification, mass spectrometry, DDI2 knockout, proteomic ubiquitylation mapping, nelfinavir inhibition","pmids":["39116872","39384955","32344880"],"confidence":"High","gaps":["Spatial coordination of ENGASE/ARIH1/DDI2 steps not defined","Physiological triggers tuning this switch incompletely characterized"]},{"year":null,"claim":"How NFE2L1 integrates its mitochondrial-biogenesis and proteostasis programs within a single cell, and how isoform balance and metabolic sensing (e.g., AMPK inhibition) are coordinated in vivo, remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking respiratory-gene activation and proteasome bounce-back","Direct AMPK-inhibition mechanism rests on single-lab Co-IP","In vivo determinants of isoform choice unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,3,19]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,13,20]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[20,23]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,20]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[23]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,20]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[20,23,28,29]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[20,25,26]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[8,17,34]}],"complexes":[],"partners":["MAFG","MAFK","PRC","PGC-1Α","PGC-1Β","PARP-1","AMPK","DDI2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14494","full_name":"Endoplasmic reticulum membrane sensor NFE2L1","aliases":["Locus control region-factor 1","LCR-F1","Nuclear factor erythroid 2-related factor 1","NF-E2-related factor 1","NFE2-related factor 1","Nuclear factor, erythroid derived 2, like 1","Protein NRF1, p120 form","Transcription factor 11","TCF-11"],"length_aa":772,"mass_kda":84.7,"function":"Endoplasmic reticulum membrane sensor that translocates into the nucleus in response to various stresses to act as a transcription factor (PubMed:20932482, PubMed:24448410). Constitutes a precursor of the transcription factor NRF1 (By similarity). Able to detect various cellular stresses, such as cholesterol excess, oxidative stress or proteasome inhibition (PubMed:20932482). In response to stress, it is released from the endoplasmic reticulum membrane following cleavage by the protease DDI2 and translocates into the nucleus to form the transcription factor NRF1 (By similarity). Acts as a key sensor of cholesterol excess: in excess cholesterol conditions, the endoplasmic reticulum membrane form of the protein directly binds cholesterol via its CRAC motif, preventing cleavage and release of the transcription factor NRF1, thereby allowing expression of genes promoting cholesterol removal, such as CD36 (By similarity). Involved in proteasome homeostasis: in response to proteasome inhibition, it is released from the endoplasmic reticulum membrane, translocates to the nucleus and activates expression of genes encoding proteasome subunits (PubMed:20932482) CNC-type bZIP family transcription factor that translocates to the nucleus and regulates expression of target genes in response to various stresses (PubMed:8932385, PubMed:9421508). Heterodimerizes with small-Maf proteins (MAFF, MAFG or MAFK) and binds DNA motifs including the antioxidant response elements (AREs), which regulate expression of genes involved in oxidative stress response (PubMed:8932385, PubMed:9421508). Activates or represses expression of target genes, depending on the context (PubMed:8932385, PubMed:9421508). Plays a key role in cholesterol homeostasis by acting as a sensor of cholesterol excess: in low cholesterol conditions, translocates into the nucleus and represses expression of genes involved in defense against cholesterol excess, such as CD36 (By similarity). In excess cholesterol conditions, the endoplasmic reticulum membrane form of the protein directly binds cholesterol via its CRAC motif, preventing cleavage and release of the transcription factor NRF1, thereby allowing expression of genes promoting cholesterol removal (By similarity). Critical for redox balance in response to oxidative stress: acts by binding the AREs motifs on promoters and mediating activation of oxidative stress response genes, such as GCLC, GCLM, GSS, MT1 and MT2 (By similarity). Plays an essential role during fetal liver hematopoiesis: probably has a protective function against oxidative stress and is involved in lipid homeostasis in the liver (By similarity). Involved in proteasome homeostasis: in response to proteasome inhibition, mediates the 'bounce-back' of proteasome subunits by translocating into the nucleus and activating expression of genes encoding proteasome subunits (PubMed:20932482). Also involved in regulating glucose flux (By similarity). Together with CEBPB; represses expression of DSPP during odontoblast differentiation (PubMed:15308669). In response to ascorbic acid induction, activates expression of SP7/Osterix in osteoblasts","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14494/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFE2L1","classification":"Not Classified","n_dependent_lines":69,"n_total_lines":1208,"dependency_fraction":0.057119205298013245},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NFE2L1","total_profiled":1310},"omim":[{"mim_id":"616770","title":"MICRO RNA 218-1; MIR218-1","url":"https://www.omim.org/entry/616770"},{"mim_id":"605327","title":"NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED; NFIL3","url":"https://www.omim.org/entry/605327"},{"mim_id":"605284","title":"TSC COMPLEX SUBUNIT 1; TSC1","url":"https://www.omim.org/entry/605284"},{"mim_id":"604135","title":"NUCLEAR FACTOR ERYTHROID 2-LIKE 3; NFE2L3","url":"https://www.omim.org/entry/604135"},{"mim_id":"603753","title":"UBIQUITINATION FACTOR E4A; UBE4A","url":"https://www.omim.org/entry/603753"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":1273.4},{"tissue":"tongue","ntpm":800.7}],"url":"https://www.proteinatlas.org/search/NFE2L1"},"hgnc":{"alias_symbol":["NRF1","LCR-F1","FLJ00380","NRF-1"],"prev_symbol":["TCF11"]},"alphafold":{"accession":"Q14494","domains":[{"cath_id":"-","chopping":"736-766","consensus_level":"medium","plddt":75.1174,"start":736,"end":766}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14494","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14494-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14494-F1-predicted_aligned_error_v6.png","plddt_mean":54.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFE2L1","jax_strain_url":"https://www.jax.org/strain/search?query=NFE2L1"},"sequence":{"accession":"Q14494","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14494.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14494/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14494"}},"corpus_meta":[{"pmid":"15684387","id":"PMC_15684387","title":"Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15684387","citation_count":557,"is_preprint":false},{"pmid":"11701451","id":"PMC_11701451","title":"Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis.","date":"2001","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11701451","citation_count":449,"is_preprint":false},{"pmid":"2166701","id":"PMC_2166701","title":"NRF-1: a trans-activator of nuclear-encoded respiratory genes in animal cells.","date":"1990","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2166701","citation_count":379,"is_preprint":false},{"pmid":"20932482","id":"PMC_20932482","title":"Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20932482","citation_count":313,"is_preprint":false},{"pmid":"8253388","id":"PMC_8253388","title":"NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8253388","citation_count":300,"is_preprint":false},{"pmid":"9501099","id":"PMC_9501099","title":"Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9501099","citation_count":243,"is_preprint":false},{"pmid":"2547796","id":"PMC_2547796","title":"Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2547796","citation_count":213,"is_preprint":false},{"pmid":"10777619","id":"PMC_10777619","title":"Sequential serum-dependent activation of CREB and NRF-1 leads to enhanced mitochondrial respiration through the induction of cytochrome c.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10777619","citation_count":153,"is_preprint":false},{"pmid":"20561910","id":"PMC_20561910","title":"PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha.","date":"2010","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/20561910","citation_count":128,"is_preprint":false},{"pmid":"21595933","id":"PMC_21595933","title":"PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.","date":"2011","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/21595933","citation_count":120,"is_preprint":false},{"pmid":"1348057","id":"PMC_1348057","title":"Nuclear respiratory factor 1 activation sites in genes encoding the gamma-subunit of ATP synthase, eukaryotic initiation factor 2 alpha, and tyrosine aminotransferase. Specific interaction of purified NRF-1 with multiple target genes.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1348057","citation_count":110,"is_preprint":false},{"pmid":"9421508","id":"PMC_9421508","title":"Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription.","date":"1998","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9421508","citation_count":105,"is_preprint":false},{"pmid":"9087432","id":"PMC_9087432","title":"The bZIP transcription factor LCR-F1 is essential for mesoderm formation in mouse development.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9087432","citation_count":99,"is_preprint":false},{"pmid":"12533512","id":"PMC_12533512","title":"c-MYC apoptotic function is mediated by NRF-1 target genes.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12533512","citation_count":99,"is_preprint":false},{"pmid":"26947393","id":"PMC_26947393","title":"Nuclear Factor Erythroid-2 Like 1 (NFE2L1): Structure, function and regulation.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26947393","citation_count":97,"is_preprint":false},{"pmid":"16908542","id":"PMC_16908542","title":"PGC-1-related coactivator: immediate early expression and characterization of a CREB/NRF-1 binding domain associated with cytochrome c promoter occupancy and respiratory growth.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16908542","citation_count":94,"is_preprint":false},{"pmid":"35271393","id":"PMC_35271393","title":"Ferroptosis regulation by the NGLY1/NFE2L1 pathway.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35271393","citation_count":85,"is_preprint":false},{"pmid":"8932385","id":"PMC_8932385","title":"Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1.","date":"1996","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8932385","citation_count":82,"is_preprint":false},{"pmid":"11058604","id":"PMC_11058604","title":"Interaction of the transcription factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11058604","citation_count":77,"is_preprint":false},{"pmid":"21856379","id":"PMC_21856379","title":"Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21856379","citation_count":71,"is_preprint":false},{"pmid":"11342101","id":"PMC_11342101","title":"TCF11/Nrf1 overexpression increases the intracellular glutathione level and can transactivate the gamma-glutamylcysteine synthetase (GCS) heavy subunit promoter.","date":"2001","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11342101","citation_count":62,"is_preprint":false},{"pmid":"23840004","id":"PMC_23840004","title":"Expression profiling of Aldh1l1-precursors in the developing spinal cord reveals glial lineage-specific genes and direct Sox9-Nfe2l1 interactions.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/23840004","citation_count":58,"is_preprint":false},{"pmid":"17928287","id":"PMC_17928287","title":"Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17928287","citation_count":53,"is_preprint":false},{"pmid":"19181665","id":"PMC_19181665","title":"Poly(ADP-ribose) Polymerase 1 Interacts with Nuclear Respiratory Factor 1 (NRF-1) and Plays a Role in NRF-1 Transcriptional Regulation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19181665","citation_count":50,"is_preprint":false},{"pmid":"37473701","id":"PMC_37473701","title":"Unravelling the role of NFE2L1 in stress responses and related diseases.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37473701","citation_count":49,"is_preprint":false},{"pmid":"34999280","id":"PMC_34999280","title":"NFE2L1-mediated proteasome function protects from ferroptosis.","date":"2022","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34999280","citation_count":47,"is_preprint":false},{"pmid":"9492280","id":"PMC_9492280","title":"Promoter analysis of the human succinate dehydrogenase iron-protein gene--both nuclear respiratory factors NRF-1 and NRF-2 are required.","date":"1998","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9492280","citation_count":46,"is_preprint":false},{"pmid":"11069771","id":"PMC_11069771","title":"Dynein light chain interacts with NRF-1 and EWG, structurally and functionally related transcription factors from humans and drosophila.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11069771","citation_count":45,"is_preprint":false},{"pmid":"11025215","id":"PMC_11025215","title":"Expression of the bZIP transcription factor TCF11 and its potential dimerization partners during development.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11025215","citation_count":43,"is_preprint":false},{"pmid":"32366381","id":"PMC_32366381","title":"NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.","date":"2020","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32366381","citation_count":42,"is_preprint":false},{"pmid":"14747477","id":"PMC_14747477","title":"Alpha-Pal/NRF-1 regulates the promoter of the human integrin-associated protein/CD47 gene.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14747477","citation_count":40,"is_preprint":false},{"pmid":"24451648","id":"PMC_24451648","title":"PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation.","date":"2014","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/24451648","citation_count":40,"is_preprint":false},{"pmid":"29935181","id":"PMC_29935181","title":"Adipocyte-specific deficiency of Nfe2l1 disrupts plasticity of white adipose tissues and metabolic homeostasis in mice.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29935181","citation_count":37,"is_preprint":false},{"pmid":"18364745","id":"PMC_18364745","title":"NRF-1 is the major transcription factor regulating the expression of the human TOMM34 gene.","date":"2008","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/18364745","citation_count":37,"is_preprint":false},{"pmid":"31632523","id":"PMC_31632523","title":"ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31632523","citation_count":35,"is_preprint":false},{"pmid":"25779891","id":"PMC_25779891","title":"Expression of Mitochondria-Associated Genes (PPARGC1A, NRF-1, BCL-2 and BAX) in Follicular Development and Atresia of Goat Ovaries.","date":"2015","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/25779891","citation_count":35,"is_preprint":false},{"pmid":"9575220","id":"PMC_9575220","title":"Activation of the cytochrome c gene by electrical stimulation in neonatal rat cardiac myocytes. Role of NRF-1 and c-Jun.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9575220","citation_count":35,"is_preprint":false},{"pmid":"27345029","id":"PMC_27345029","title":"TCF11/Nrf1-Mediated Induction of Proteasome Expression Prevents Cytotoxicity by Rotenone.","date":"2016","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27345029","citation_count":34,"is_preprint":false},{"pmid":"7557987","id":"PMC_7557987","title":"Structural organization and mapping of the human TCF11 gene.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7557987","citation_count":34,"is_preprint":false},{"pmid":"25806530","id":"PMC_25806530","title":"Icariin induces synoviolin expression through NFE2L1 to protect neurons from ER stress-induced apoptosis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25806530","citation_count":33,"is_preprint":false},{"pmid":"11278371","id":"PMC_11278371","title":"Two domains of the human bZIP transcription factor TCF11 are necessary for transactivation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278371","citation_count":32,"is_preprint":false},{"pmid":"30287392","id":"PMC_30287392","title":"Mechanisms controlling the multistage post-translational processing of endogenous Nrf1α/TCF11 proteins to yield distinct isoforms within the coupled positive and negative feedback circuits.","date":"2018","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30287392","citation_count":31,"is_preprint":false},{"pmid":"32344880","id":"PMC_32344880","title":"Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32344880","citation_count":30,"is_preprint":false},{"pmid":"17883938","id":"PMC_17883938","title":"Icariin promotes expression of PGC-1alpha, PPARalpha, and NRF-1 during cardiomyocyte differentiation of murine embryonic stem cells in vitro.","date":"2007","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/17883938","citation_count":30,"is_preprint":false},{"pmid":"15175277","id":"PMC_15175277","title":"Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15175277","citation_count":30,"is_preprint":false},{"pmid":"31911660","id":"PMC_31911660","title":"Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.","date":"2020","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/31911660","citation_count":29,"is_preprint":false},{"pmid":"15992771","id":"PMC_15992771","title":"A novel function of transcription factor alpha-Pal/NRF-1: increasing neurite outgrowth.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15992771","citation_count":29,"is_preprint":false},{"pmid":"10575350","id":"PMC_10575350","title":"Expression of mitochondrial genes and of the transcription factors involved in the biogenesis of mitochondria Tfam, NRF-1 and NRF-2, in rat liver, testis and brain.","date":"1999","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/10575350","citation_count":29,"is_preprint":false},{"pmid":"39116872","id":"PMC_39116872","title":"Sugar-mediated non-canonical ubiquitination impairs Nrf1/NFE2L1 activation.","date":"2024","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/39116872","citation_count":28,"is_preprint":false},{"pmid":"35614059","id":"PMC_35614059","title":"Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35614059","citation_count":28,"is_preprint":false},{"pmid":"37243831","id":"PMC_37243831","title":"EIF4A3-Induced Exosomal circLRRC8A Alleviates Granulosa Cells Senescence Via the miR-125a-3p/NFE2L1 axis.","date":"2023","source":"Stem cell reviews and reports","url":"https://pubmed.ncbi.nlm.nih.gov/37243831","citation_count":28,"is_preprint":false},{"pmid":"7759107","id":"PMC_7759107","title":"Cloning and mapping of murine Nfe2l1.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7759107","citation_count":28,"is_preprint":false},{"pmid":"37658135","id":"PMC_37658135","title":"The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37658135","citation_count":28,"is_preprint":false},{"pmid":"30267375","id":"PMC_30267375","title":"AMPK Activation of PGC-1α/NRF-1-Dependent SELENOT Gene Transcription Promotes PACAP-Induced Neuroendocrine Cell Differentiation Through Tolerance to Oxidative Stress.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/30267375","citation_count":26,"is_preprint":false},{"pmid":"30186109","id":"PMC_30186109","title":"Nuclear Respiratory Factor 1 (NRF-1) Controls the Activity Dependent Transcription of the GABA-A Receptor Beta 1 Subunit Gene in Neurons.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30186109","citation_count":26,"is_preprint":false},{"pmid":"32942643","id":"PMC_32942643","title":"Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32942643","citation_count":25,"is_preprint":false},{"pmid":"28549828","id":"PMC_28549828","title":"Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity.","date":"2017","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28549828","citation_count":25,"is_preprint":false},{"pmid":"18234454","id":"PMC_18234454","title":"NRF-1, and AP-1 regulate the promoter of the human calpain small subunit 1 (CAPNS1) gene.","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/18234454","citation_count":25,"is_preprint":false},{"pmid":"19433258","id":"PMC_19433258","title":"Involvement of PGC-1, NRF-1, and NRF-2 in metabolic response by rat liver to hormonal and environmental signals.","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19433258","citation_count":25,"is_preprint":false},{"pmid":"28263745","id":"PMC_28263745","title":"Exercise increases hyper-acetylation of histones on the Cis-element of NRF-1 binding to the Mef2a promoter: Implications on type 2 diabetes.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28263745","citation_count":25,"is_preprint":false},{"pmid":"12059978","id":"PMC_12059978","title":"Upregulation and activation of the Nrf-1 transcription factor in the lesioned hippocampus.","date":"2002","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12059978","citation_count":24,"is_preprint":false},{"pmid":"32810507","id":"PMC_32810507","title":"NRF-1 and HIF-1α contribute to modulation of human VDAC1 gene promoter during starvation and hypoxia in HeLa cells.","date":"2020","source":"Biochimica et biophysica acta. Bioenergetics","url":"https://pubmed.ncbi.nlm.nih.gov/32810507","citation_count":24,"is_preprint":false},{"pmid":"15479157","id":"PMC_15479157","title":"The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15479157","citation_count":24,"is_preprint":false},{"pmid":"27491637","id":"PMC_27491637","title":"Nuclear respiratory factor-1 (NRF-1) regulated hypoxia-inducible factor-1α (HIF-1α) under hypoxia in HEK293T.","date":"2016","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/27491637","citation_count":23,"is_preprint":false},{"pmid":"9108165","id":"PMC_9108165","title":"Role of NRF-1 in bidirectional transcription of the human GPAT-AIRC purine biosynthesis locus.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9108165","citation_count":23,"is_preprint":false},{"pmid":"34763297","id":"PMC_34763297","title":"CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34763297","citation_count":22,"is_preprint":false},{"pmid":"34102194","id":"PMC_34102194","title":"Vitamin D and rosuvastatin obliterate peripheral neuropathy in a type-2 diabetes model through modulating Notch1, Wnt-10α, TGF-β and NRF-1 crosstalk.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34102194","citation_count":22,"is_preprint":false},{"pmid":"34058615","id":"PMC_34058615","title":"The roles of NFE2L1 in adipocytes: Structural and mechanistic insight from cell and mouse models.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34058615","citation_count":21,"is_preprint":false},{"pmid":"29203613","id":"PMC_29203613","title":"Nfe2l1-silenced insulinoma cells acquire aggressiveness and chemoresistance.","date":"2017","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29203613","citation_count":21,"is_preprint":false},{"pmid":"12729924","id":"PMC_12729924","title":"Cellular localisation and nuclear export of the human bZIP transcription factor TCF11.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12729924","citation_count":21,"is_preprint":false},{"pmid":"32543769","id":"PMC_32543769","title":"Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the blood-brain barrier.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32543769","citation_count":21,"is_preprint":false},{"pmid":"29801148","id":"PMC_29801148","title":"Tetramethylpyrazine in a Murine Alkali-Burn Model Blocks NFκB/NRF-1/CXCR4-Signaling-Induced Corneal Neovascularization.","date":"2018","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/29801148","citation_count":21,"is_preprint":false},{"pmid":"32762035","id":"PMC_32762035","title":"SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32762035","citation_count":20,"is_preprint":false},{"pmid":"23892277","id":"PMC_23892277","title":"Estradiol and tamoxifen regulate NRF-1 and mitochondrial function in mouse mammary gland and uterus.","date":"2013","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23892277","citation_count":20,"is_preprint":false},{"pmid":"38150994","id":"PMC_38150994","title":"NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38150994","citation_count":19,"is_preprint":false},{"pmid":"36046786","id":"PMC_36046786","title":"Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion via stimulation of fatty acid oxidation-linked respiration and PGC-1α/NRF-1 signaling.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36046786","citation_count":19,"is_preprint":false},{"pmid":"21172391","id":"PMC_21172391","title":"The kinesin superfamily protein KIF17 is regulated by the same transcription factor (NRF-1) as its cargo NR2B in neurons.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21172391","citation_count":19,"is_preprint":false},{"pmid":"39384955","id":"PMC_39384955","title":"Activating the NFE2L1-ubiquitin-proteasome system by DDI2 protects from ferroptosis.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/39384955","citation_count":18,"is_preprint":false},{"pmid":"23085505","id":"PMC_23085505","title":"Nuclear respiratory factor 2 regulates the expression of the same NMDA receptor subunit genes as NRF-1: both factors act by a concurrent and parallel mechanism to couple energy metabolism and synaptic transmission.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23085505","citation_count":18,"is_preprint":false},{"pmid":"37450596","id":"PMC_37450596","title":"Overexpression of Nfe2l1 increases proteasome activity and delays vision loss in a preclinical model of human blindness.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37450596","citation_count":17,"is_preprint":false},{"pmid":"21412055","id":"PMC_21412055","title":"TCF11 at the crossroads of oxidative stress and the ubiquitin proteasome system.","date":"2011","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21412055","citation_count":17,"is_preprint":false},{"pmid":"34268128","id":"PMC_34268128","title":"TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34268128","citation_count":17,"is_preprint":false},{"pmid":"23939472","id":"PMC_23939472","title":"Novel genes FAM134C, C3orf10 and ENOX1 are regulated by NRF-1 and differentially regulate neurite outgrowth in neuroblastoma cells and hippocampal neurons.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23939472","citation_count":17,"is_preprint":false},{"pmid":"37759569","id":"PMC_37759569","title":"Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases.","date":"2023","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37759569","citation_count":16,"is_preprint":false},{"pmid":"34536977","id":"PMC_34536977","title":"LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway.","date":"2021","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/34536977","citation_count":16,"is_preprint":false},{"pmid":"35569770","id":"PMC_35569770","title":"Effects of NRF-1 and PGC-1α cooperation on HIF-1α and rat cardiomyocyte apoptosis under hypoxia.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35569770","citation_count":16,"is_preprint":false},{"pmid":"35727472","id":"PMC_35727472","title":"Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.","date":"2022","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/35727472","citation_count":16,"is_preprint":false},{"pmid":"30233383","id":"PMC_30233383","title":"Benfotiamine, a Lipid-Soluble Analog of Vitamin B1, Improves the Mitochondrial Biogenesis and Function in Blunt Snout Bream (Megalobrama amblycephala) Fed High-Carbohydrate Diets by Promoting the AMPK/PGC-1β/NRF-1 Axis.","date":"2018","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30233383","citation_count":16,"is_preprint":false},{"pmid":"28993637","id":"PMC_28993637","title":"HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28993637","citation_count":15,"is_preprint":false},{"pmid":"33838154","id":"PMC_33838154","title":"Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells.","date":"2021","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33838154","citation_count":15,"is_preprint":false},{"pmid":"35124418","id":"PMC_35124418","title":"Long-isoform NFE2L1 silencing inhibits acquisition of malignant phenotypes induced by arsenite in human bronchial epithelial cells.","date":"2022","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/35124418","citation_count":14,"is_preprint":false},{"pmid":"34902807","id":"PMC_34902807","title":"Feedback regulation of antioxidant transcription factor NFE2L1 and immunostimulatory factor 41BBL mediates the crosstalk between oxidative stress and tumor immunity.","date":"2021","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34902807","citation_count":14,"is_preprint":false},{"pmid":"21609478","id":"PMC_21609478","title":"Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex.","date":"2011","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21609478","citation_count":14,"is_preprint":false},{"pmid":"27634749","id":"PMC_27634749","title":"Elucidation of the therapeutic role of mitochondrial biogenesis transducers NRF-1 in the regulation of renal fibrosis.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27634749","citation_count":14,"is_preprint":false},{"pmid":"15257658","id":"PMC_15257658","title":"The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activity.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15257658","citation_count":13,"is_preprint":false},{"pmid":"37848756","id":"PMC_37848756","title":"NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma.","date":"2023","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/37848756","citation_count":12,"is_preprint":false},{"pmid":"33137425","id":"PMC_33137425","title":"Protracted rosiglitazone treatment exacerbates inflammation in white adipose tissues of adipocyte-specific Nfe2l1 knockout mice.","date":"2020","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/33137425","citation_count":12,"is_preprint":false},{"pmid":"39255868","id":"PMC_39255868","title":"Neonatal high-dose riboflavin treatment channels energy expenditure towards sensorimotor and somatic development and reduces rodent growth and weight gain by modulating NRF-1 in the hypothalamus.","date":"2024","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/39255868","citation_count":12,"is_preprint":false},{"pmid":"34345304","id":"PMC_34345304","title":"NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34345304","citation_count":11,"is_preprint":false},{"pmid":"39061827","id":"PMC_39061827","title":"Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer.","date":"2024","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/39061827","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52436,"output_tokens":9729,"usd":0.151621,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19963,"output_tokens":4589,"usd":0.10727,"stage2_stop_reason":"end_turn"},"total_usd":0.258891,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"NRF-1 (NFE2L1) was identified as a sequence-specific transcriptional activator binding to a recognition element in the rat somatic cytochrome c promoter; mutational analysis showed the NRF-1 site is required for maximal cytochrome c promoter activity, and the factor makes specific guanine nucleotide contacts within its recognition sequence.\",\n      \"method\": \"Promoter mutational analysis, DNA-binding/competition assays, in vivo transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding, mutagenesis, and in vivo promoter assays; foundational paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"2547796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"NRF-1 functions as a trans-activator of multiple nuclear-encoded respiratory genes (cytochrome c, cytochrome oxidase subunit VIc, ubiquinone-binding protein of reductase complex, MRP RNA gene); NRF-1-binding activities for each site copurify chromatographically, have the same thermal lability, and make similar guanine nucleotide contacts, indicating a single factor recognizes all sites; in vitro recognition correlates with in vivo transcriptional activation.\",\n      \"method\": \"DNA competition binding assays, chromatographic copurification, methylation interference footprinting, in vivo transfection assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods (copurification, footprinting, in vivo assays) with multiple target genes\",\n      \"pmids\": [\"2166701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"NRF-1 directly binds and activates functional recognition sites in the ATP synthase γ-subunit gene (complex V), eukaryotic initiation factor 2α gene, and tyrosine aminotransferase gene; the binding activities for all sites copurify ~33,000-fold and reside in a single 68-kDa protein.\",\n      \"method\": \"Competition binding assays, methylation interference footprinting, UV-induced DNA cross-linking, chromatographic copurification, transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods, purification to single protein, in vivo confirmation\",\n      \"pmids\": [\"1348057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The NRF-1 DNA-binding domain was mapped to the amino-terminal half of the protein by deletion analysis; cloning revealed NRF-1 defines a new class of DNA-binding proteins sharing sequence identity with sea urchin P3A2 and Drosophila EWG; recombinant NRF-1 reproduced the DNA-binding specificity and transcriptional activation of authentic HeLa NRF-1.\",\n      \"method\": \"cDNA cloning from HeLa cells using tryptic peptide sequences, deletion mapping, recombinant protein production, transcription activation assays, antiserum supershift\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cDNA cloning with biochemical validation, deletion mapping of functional domain, multiple orthogonal methods in one study\",\n      \"pmids\": [\"8253388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TCF11/NFE2L1 forms heterodimers with small Maf proteins (MafG, MafK); heterodimerization with small Maf proteins alters DNA-binding characteristics of TCF11, producing stronger binding to NF-E2 sites than TCF11 alone; TCF11 isoforms bound to NF-E2 sites were detected in K562 erythroid cell nuclear extracts by antibody supershift.\",\n      \"method\": \"In vitro heterodimerization assays, EMSA/supershift assays, antibody detection in nuclear extracts\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding assays plus in-cell nuclear extract confirmation, replicated in follow-up paper (PMID:9421508)\",\n      \"pmids\": [\"8932385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LCR-F1/NFE2L1 is essential for gastrulation in mice; homozygous null embryos fail to form a primitive streak and lack detectable mesoderm, demonstrating a non-cell-autonomous role; LCR-F1 null ES cells contribute normally to mesodermally derived tissues including erythroid cells in chimeras, indicating the function is mediated through signaling molecules rather than cell-intrinsic globin gene regulation.\",\n      \"method\": \"Gene targeting/knockout in mouse ES cells, blastocyst injection chimeras, developmental phenotype analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined developmental phenotype, epistasis established via chimera rescue\",\n      \"pmids\": [\"9087432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TCF11/NFE2L1 and MafG form a heterodimer that preferentially recognizes the NF-E2/antioxidant response element (ARE) sequence 5'-TGCTgaGTCAT-3'; MafG alone acts as a transcriptional repressor, while TCF11 alone activates transcription; when co-expressed, MafG inhibits TCF11 transactivation in a dose-dependent manner despite the higher DNA affinity of the heterodimer.\",\n      \"method\": \"Binding-site selection assay (SELEX), transient transfection reporter assays, in vitro dimerization assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — SELEX for binding-site definition plus functional reporter assays, single lab but multiple methods\",\n      \"pmids\": [\"9421508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Homozygous disruption of Nrf1/NFE2L1 in mice causes anemia due to a non-cell-autonomous defect in definitive erythropoiesis and embryonic lethality in utero.\",\n      \"method\": \"Targeted gene disruption in mice (knockout), histological and hematological analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype; independently consistent with LCR-F1 KO paper (PMID:9087432)\",\n      \"pmids\": [\"9501099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"NRF-1 binding sites in both human TFB1M and TFB2M (mitochondrial transcription specificity factor) promoters are required for maximal trans-activation by PGC-1α and PRC coactivators; ectopic expression of PGC-1α induces TFB1M, TFB2M, and Tfam coordinately along with NRF-1 target respiratory subunits.\",\n      \"method\": \"Promoter mutational analysis, transient transfection reporter assays, ectopic expression of PGC-1α\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — NRF-1 site mutagenesis plus ectopic coactivator expression; independently validated by PGC-1β study (PMID:20561910)\",\n      \"pmids\": [\"15684387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NRF-1 is phosphorylated sequentially after serum stimulation, and this phosphorylation increases its trans-activation activity on the cytochrome c promoter, leading to enhanced mitochondrial respiration; both NRF-1 and CREB binding sites contribute equally to serum-induced cytochrome c expression.\",\n      \"method\": \"Promoter mutant transfections, phosphorylation analysis, mitochondrial respiration measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods in one lab (promoter mutants + phosphorylation assays + respiration), single lab\",\n      \"pmids\": [\"10777619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Dynein light chain physically interacts with NRF-1, requiring the first 26 amino acids of NRF-1; interaction was confirmed by yeast two-hybrid screening, chemical crosslinking of purified native proteins, and co-immunoprecipitation from mammalian cells; both NRF-1 and dynein light chain display similar nuclear staining patterns. The same interaction is conserved with Drosophila EWG, which also binds and trans-activates through NRF-1 binding sites.\",\n      \"method\": \"Yeast two-hybrid screening, chemical crosslinking of purified proteins, co-immunoprecipitation, immunolocalization/confocal microscopy, transcription assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Y2H + crosslinking of purified proteins + co-IP + immunolocalization) in one study\",\n      \"pmids\": [\"11069771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NRF-1 (alpha-Pal/Nrf-1) binds the FMR1 promoter in brain and testis extracts; methylation of the NRF-1 site abolishes NRF-1 binding to the FMR1 promoter, suggesting that DNA methylation silences FMR1 in part by blocking NRF-1 access.\",\n      \"method\": \"EMSA with nuclear extracts, transcription factor binding-site analysis, methylation interference\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus methylation-blocking experiment, single lab\",\n      \"pmids\": [\"11058604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TCF11/NFE2L1 transactivates the GCS heavy subunit (GCS-h) promoter through antioxidant response elements (AREs), with EMSA showing TCF11 binds one specific ARE as a heterodimer with small Maf proteins; TCF11 overexpression increases intracellular glutathione levels in COS-1 cells.\",\n      \"method\": \"Overexpression in COS-1 cells, co-transfection reporter assays, EMSA, glutathione measurement\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with deletion/mutation plus EMSA and cellular phenotype, single lab\",\n      \"pmids\": [\"11342101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Full-length TCF11 requires two separate transactivation domains (an N-terminal acidic domain and a serine-rich stretch adjacent to the CNC-bZIP domains) for transcriptional activity; the shorter LCR-F1 isoform lacks transactivation ability but can act as a dominant-negative inhibitor of the full-length form, providing an isoform-based regulatory mechanism.\",\n      \"method\": \"Domain deletion/swapping mutants, transient transfection reporter assays in multiple cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic deletion/swap mutagenesis with reporter assays, single lab\",\n      \"pmids\": [\"11278371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"c-Myc directly activates cytochrome c gene expression through NRF-1 target sites; NRF-1 overexpression sensitizes cells to apoptosis on serum depletion; dominant-negative NRF-1 prevents c-Myc-induced apoptosis without affecting c-Myc-dependent proliferation, placing NRF-1 downstream of c-Myc specifically in the apoptotic branch.\",\n      \"method\": \"Northern analysis, transactivation assays, in vitro and in vivo promoter binding assays, dominant-negative NRF-1 expression, apoptosis assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods including dominant-negative epistasis, in vitro and in vivo promoter binding, and functional cell death assays\",\n      \"pmids\": [\"12533512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TCF11/NFE2L1 is exported from the nucleus via a nuclear export signal (NES) in its N-terminus through the CRM1/exportin pathway; the full-length form is both cytoplasmic and nuclear, while the shorter internally initiated isoform is restricted to the nucleus; mutating three leucine residues in the NES largely blocks export. Alternative-splicing isoforms lacking the NES are constitutively nuclear.\",\n      \"method\": \"Cellular fractionation, immunofluorescence localization, leptomycin B treatment, NES mutagenesis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization experiments with pharmacological and mutagenesis confirmation, functional consequence (isoform nuclear restriction) defined\",\n      \"pmids\": [\"12729924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NRF-1 (alpha-Pal/NRF-1) occupies the FMR1 promoter in vivo (chromatin immunoprecipitation); NRF-1 and Sp1 synergistically activate FMR1 transcription; NRF-1 transactivation is sensitive to dense CpG methylation of the promoter; siRNA knockdown of endogenous NRF-1 reduces FMR1 reporter activity in HeLa cells.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), transient transfection reporter assays, siRNA knockdown, methylation sensitivity assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo ChIP plus siRNA knockdown with functional readout and methylation-sensitivity experiments, multiple orthogonal methods\",\n      \"pmids\": [\"15175277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PRC (PGC-1-related coactivator) physically binds NRF-1 in vitro and forms a complex with NRF-1 in cell extracts; CREB also binds PRC at overlapping sites; a CREB/NRF-1 interaction domain on PRC is required for transactivation of the cytochrome c promoter; PRC occupies the cytochrome c promoter in vivo and its occupancy is elevated upon serum induction.\",\n      \"method\": \"In vitro binding assays, co-immunoprecipitation from cell extracts, chromatin immunoprecipitation, dominant-negative lentivirus expression, respiratory growth assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus in vitro binding plus ChIP plus functional respiratory growth assay, multiple orthogonal methods\",\n      \"pmids\": [\"16908542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TCF11/MafG heterodimer binds an element in the iNOS promoter (identified by ChIP and mutation analyses) and represses iNOS induction; TGF-β1 induces TCF11/MafG binding to this site via a protein kinase C-dependent mechanism; siRNA knockdown of TCF11 blocks TGF-β-mediated suppression of iNOS.\",\n      \"method\": \"Chromatin immunoprecipitation, promoter mutation analysis, siRNA knockdown, PKC inhibitor studies, in vivo rat endotoxemia model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, mutagenesis, siRNA, pharmacological inhibition, and in vivo model; multiple orthogonal methods\",\n      \"pmids\": [\"17928287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NRF-1 directly interacts with PARP-1 and co-purifies a PARP-1·DNA-PK·Ku80·Ku70·topoisomerase IIβ-containing complex; the DNA-binding/dimerization domain of NRF-1 and the N-terminal zinc finger/auto-modification domain of PARP-1 mediate the interaction; DNA-bound NRF-1 can recruit this complex to promoters; PARP-1 can PARylate the DNA-binding domain of NRF-1 and negatively regulate the NRF-1·PARP-1 interaction.\",\n      \"method\": \"In vitro binding assays, co-purification, domain mapping, PARylation assay, ChIP, transient transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro biochemical reconstitution, domain mapping, PARylation assay, and in-cell ChIP; multiple orthogonal methods\",\n      \"pmids\": [\"19181665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TCF11 (long isoform of NFE2L1) is identified as the key transcription factor driving 26S proteasome gene expression in response to proteasome inhibition (bounce-back response). Under basal conditions, TCF11 resides in the ER membrane and is targeted to ER-associated degradation (ERAD) requiring E3 ubiquitin ligase HRD1 and AAA-ATPase p97; proteasome inhibition promotes nuclear translocation of TCF11, where it binds antioxidant response elements (AREs) in proteasome gene promoters.\",\n      \"method\": \"Transcription factor identification by cell-based assays, subcellular fractionation, dominant-negative ERAD component expression, promoter-binding assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — identification of ERAD-dependent regulatory mechanism with multiple genetic and biochemical tools, published in high-impact journal; foundational paper replicated by multiple labs\",\n      \"pmids\": [\"20932482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Sox9 directly regulates Nfe2l1 expression in gliogenic radial glia; Nfe2l1 promotes glial fate under direct Sox9 regulatory control in developing spinal cord.\",\n      \"method\": \"Gene expression profiling, chromatin immunoprecipitation, functional assays in developing CNS\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct Sox9-Nfe2l1 interaction plus functional glial-fate assay, single lab\",\n      \"pmids\": [\"23840004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PARK2/Parkin-mediated mitophagy is required for NFE2L1 nuclear translocation and subsequent proteasome activation during denervation-induced muscle atrophy; in both autophagy-deficient and Park2-knockout muscles, NFE2L1 nuclear translocation was absent and proteasome activation failed, while polyubiquitinated proteins accumulated.\",\n      \"method\": \"Autophagy-deficient and Park2-knockout mouse models, denervation atrophy model, subcellular fractionation, proteasome activity assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function models with defined molecular phenotype (nuclear translocation failure) and functional consequence (proteasome activation deficit)\",\n      \"pmids\": [\"24451648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NFE2L1 undergoes multi-step post-translational processing: the nascent polypeptide is transiently translocated into the ER lumen and becomes an inactive glycoprotein (glycosylation by OST); it is then retrotranslocated by p97; deglycosylated by glycosidases to yield a deglycoprotein; and proteolytically processed by cytosolic DDI-1/2 and proteasomes to generate N-terminally truncated active isoforms. Coupled positive and negative feedback circuits exist between NFE2L1 and its regulators (p97, Hrd1, DDI-1, proteasomes).\",\n      \"method\": \"Cell-based mutagenesis, glycosylation/deglycosylation assays, pharmacological inhibitors of p97/ERAD, proteasome inhibitors, western blot isoform analysis\",\n      \"journal\": \"Toxicology and applied pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical and genetic approaches mapping sequential PTM steps and feedback circuitry; consistent with other ERAD processing papers\",\n      \"pmids\": [\"30287392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFE2L1 and NFE2L3 complementarily maintain basal proteasome activity in cancer cells; double knockdown of NFE2L1 and NFE2L3 impairs basal proteasome activity and reduces expression of seven proteasome-related genes; NFE2L3 represses NFE2L1 translation via induction of CPEB3, which binds the NFE2L1 3' UTR and decreases polysome formation on NFE2L1 mRNA.\",\n      \"method\": \"Double siRNA knockdown, proteasome activity assays, mRNA polysome analysis, CPEB3 binding assays, gene expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double KD with specific proteasome activity readout plus translational repression mechanism (polysome analysis + 3' UTR binding), multiple orthogonal methods\",\n      \"pmids\": [\"32366381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NFE2L1 promotes ferroptosis resistance independent of NFE2L2 by maintaining expression of glutathione peroxidase 4 (GPX4), a key inhibitor of lethal lipid peroxidation; NFE2L2 promotes ferroptosis resistance through a distinct mechanism that appears independent of GPX4 protein expression.\",\n      \"method\": \"NFE2L1/NFE2L2 gene knockout cellular models, ferroptosis induction assays, GPX4 expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with specific ferroptosis assay, mechanistic separation of NFE2L1 vs NFE2L2 via GPX4 expression, multiple cell systems\",\n      \"pmids\": [\"35271393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NFE2L1 loss reduces cellular viability after ferroptosis induction; NFE2L1 protects from ferroptosis by sustaining proteasomal activity; Gpx4-deficient mice show reduced proteasomal activity associated with ferroptosis; Nfe2l1-deficient mice show brown adipose tissue involution, hyperubiquitination of ferroptosis regulators including the GPX4 pathway, and other ferroptosis hallmarks.\",\n      \"method\": \"NFE2L1 loss-of-function in cellular systems and mouse models (Gpx4-KO, Nfe2l1-deficient), proteasome activity assays, patient-derived cell line with GPX4 mutation\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (cell lines, patient cells, Gpx4-KO mice, Nfe2l1-deficient mice) with proteasome and ferroptosis assays\",\n      \"pmids\": [\"34999280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Glycosylation of NFE2L1 enables it to sense the energy state; loss of NFE2L1 in hepatocytes leads to lethality upon glucose deprivation and affects glucose uptake; NFE2L1 directly interacts with and inhibits AMPK (demonstrated by co-expression and co-immunoprecipitation), placing NFE2L1 as a negative regulator of AMPK signaling.\",\n      \"method\": \"NFE2L1 silencing in HepG2 cells, glucose deprivation assays, co-immunoprecipitation, transcriptome and metabolome analysis, Seahorse assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating direct NFE2L1-AMPK interaction, single lab, supported by functional readouts\",\n      \"pmids\": [\"35614059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NRF1/NFE2L1 transcriptionally induces p62/SQSTM1 and GABARAPL1 (an ATG8 family gene) after proteasome inhibition, activating aggrephagy; NRF1 is required for formation of p62-positive puncta, their colocalization with ULK1 and TBK1, and Ser403 phosphorylation of p62; NRF1 thus couples the proteasome bounce-back response to selective autophagy.\",\n      \"method\": \"Genome-wide transcriptome analysis (RNA-seq), NRF1 knockdown, immunofluorescence, co-immunoprecipitation, phosphorylation assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide target identification plus multiple functional validation methods (KD, immunofluorescence, phosphorylation assay); novel mechanism orthogonal to prior proteasome findings\",\n      \"pmids\": [\"37658135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SCFFBS2 (an N-glycan-recognizing E3 ligase) cooperates with the RBR-type E3 ligase ARIH1 to ubiquitinate NFE2L1 through oxyester bonds at N-GlcNAc residues (generated by ENGASE from N-glycans); this non-canonical ubiquitination assembles atypical ubiquitin chains (requiring UBE2L3) and inhibits DDI2-mediated proteolytic activation of NFE2L1. The polyubiquitination was biochemically reconstituted on glycopeptides.\",\n      \"method\": \"In vitro reconstitution of polyubiquitination on glycopeptides, identification of SCFFBS2-ARIH1 E3 complex, ENGASE activity assay, mass spectrometry of ubiquitination sites, cell-based NFE2L1 activation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution of ubiquitination on glycopeptides plus identification of E3 complex and UBE2 requirement plus cell-based functional consequence; rigorous multi-method study\",\n      \"pmids\": [\"39116872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DDI2 protease-mediated proteolytic cleavage of NFE2L1 is a critical step for ferroptosis-induced feedback activation of proteasome function; cells lacking DDI2 cannot activate NFE2L1 in response to RSL3 and show global hyperubiquitylation; ferroptosis induction leads to proteasome inhibition that activates NFE2L1 through DDI2 cleavage.\",\n      \"method\": \"DDI2 genetic disruption, proteomic ubiquitylation site mapping, RSL3-induced ferroptosis, proteasome activity assays, nelfinavir (DDI2 inhibitor) treatment\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic DDI2 KO, unbiased proteomic approach plus pharmacological inhibition and functional proteasome/cell death assays; multiple orthogonal methods\",\n      \"pmids\": [\"39384955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nelfinavir inhibits the TCF11/Nrf1-driven proteasome recovery pathway by dual mechanism: decreasing total TCF11/Nrf1 protein level and inhibiting its DDI2-mediated proteolytic processing, thereby reducing nuclear TCF11/Nrf1 and proteasome gene re-synthesis.\",\n      \"method\": \"TCF11/Nrf1 protein level and nuclear fraction analysis, proteasome gene expression assays, DDI2 inhibition in multiple myeloma cells\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic drug-target study with protein level and processing assays, single lab\",\n      \"pmids\": [\"32344880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFE2L1 regulates osteoclast differentiation in an isoform-specific manner: long isoforms of NFE2L1 accelerate Nfatc1/α induction and antioxidant gene expression, while the short isoform NFE2L1-453 suppresses these effects; myeloid-specific Nfe2l1 knockout mice show increased osteoclast activity, decreased bone mass, and worsened osteoporosis. NFE2L1 deficiency leads to enhanced ROS accumulation in early osteoclastogenesis.\",\n      \"method\": \"Myeloid-specific conditional KO (LysM-Cre), ovariectomy and aging models, bone marrow cell and RAW 264.7 cell differentiation assays, isoform-specific knockdown\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with specific bone phenotype plus mechanistic isoform dissection and multiple in vitro/in vivo models\",\n      \"pmids\": [\"34763297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Adipocyte-specific Nfe2l1 knockout mice exhibit reduced subcutaneous adipose tissue mass, insulin resistance, adipocyte hypertrophy, and severe adipose inflammation; mechanistic studies revealed Nfe2l1 deficiency disturbs expression of lipolytic genes in adipocytes, leading to adipocyte hypertrophy followed by inflammation and pyroptosis.\",\n      \"method\": \"Adipocyte-specific conditional KO (Nfe2l1(f)-KO), metabolic phenotyping, gene expression analysis of lipolytic genes\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean conditional KO with defined metabolic phenotype, mechanistic link to lipolytic gene expression, single lab\",\n      \"pmids\": [\"29935181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PGC-1β promotes mitochondrial biogenesis and function in myotubes through direct interaction with NRF-1 and ERRα; deletion or mutation of NRF-1 and/or ERRα binding sites in target gene promoters attenuates PGC-1β-mediated activation; siRNA inhibition of NRF-1 or ERRα abolishes the mitochondrial biogenesis function of PGC-1β.\",\n      \"method\": \"Overexpression, siRNA knockdown, promoter deletion/mutation reporter assays, co-immunoprecipitation\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction confirmed by Co-IP, promoter mutagenesis, and siRNA functional assays; single lab\",\n      \"pmids\": [\"20561910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HTLV-1 bZIP factor (HBZ) physically interacts with NRF-1 and inhibits NRF-1's DNA-binding ability, thereby suppressing NRF-1-dependent TDP1 gene transcription; this mechanism underlies reduced TDP1 in adult T-cell leukemia cells, making them susceptible to abacavir.\",\n      \"method\": \"Co-immunoprecipitation of HBZ and NRF-1, dominant-negative NRF-1, luciferase reporter assays, shNRF-1 knockdown\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating physical interaction plus functional reporter and knockdown assays, single lab\",\n      \"pmids\": [\"28993637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NFE2L1 overexpression stimulates proteasome biogenesis and activity in retinal neurons and delays photoreceptor neuron loss in a preclinical mouse model of human blindness caused by misfolded proteins, demonstrating that a transcription-driven increase in the proteasome pool can enhance proteolytic capacity and confer neuroprotection.\",\n      \"method\": \"Nfe2l1 adeno-associated virus overexpression in mouse retina, proteasome activity assays, ubiquitin-proteasomal reporter clearance assay, photoreceptor neuron survival analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain-of-function with functional proteasome and neurodegeneration readouts, multiple assays\",\n      \"pmids\": [\"37450596\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NFE2L1 (NRF-1/TCF11/LCR-F1) is a CNC-bZIP transcription factor that resides in the ER membrane under basal conditions, where it is glycosylated, ubiquitinated (via SCFFBS2-ARIH1 through non-canonical oxyester bonds on N-GlcNAc residues), and degraded by ERAD (requiring HRD1 and p97); upon proteasome inhibition or ferroptosis, it is retrotranslocated by p97, deglycosylated, proteolytically cleaved by DDI2, and translocated to the nucleus where it binds AREs to transcriptionally upregulate proteasome subunit genes (bounce-back response), aggrephagy mediators (p62/SQSTM1, GABARAPL1), and antioxidant genes including GCS-h and GPX4; in its role as a master regulator of nuclear-mitochondrial interactions, NRF-1 also directly activates nuclear-encoded respiratory chain subunits, mitochondrial transcription factors (Tfam, TFB1M, TFB2M), and numerous housekeeping genes, and is coactivated by PGC-1 family members (PGC-1α, PGC-1β, PRC) that bind NRF-1 directly; phosphorylation of NRF-1 by serum-stimulated kinases enhances its transactivation; it heterodimerizes with small Maf proteins (MafG/K), which modulate its DNA-binding affinity and can suppress its transactivation; it also interacts with dynein light chain (via its first 26 amino acids), PARP-1 (via its DNA-binding domain), and AMPK (directly inhibiting AMPK signaling); isoform-specific functions are established, with long isoforms (TCF11) acting as transcriptional activators and the short LCR-F1 isoform serving as a dominant-negative regulator.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NFE2L1 (NRF-1/TCF11/LCR-F1) is a CNC-bZIP transcription factor that serves dual master-regulatory roles in mitochondrial biogenesis and proteostasis [#1, #20]. It was first defined as a sequence-specific activator of nuclear-encoded respiratory genes, binding recognition elements through specific guanine contacts and trans-activating cytochrome c, cytochrome oxidase subunit VIc, ATP synthase \\u03b3-subunit, and other respiratory and housekeeping genes via a single ~68-kDa factor [#0, #1, #2]; its DNA-binding domain lies in the amino-terminal half [#3]. NRF-1 directly drives the mitochondrial transcription machinery, with NRF-1 sites in the Tfam, TFB1M, and TFB2M promoters required for coactivation by PGC-1 family members (PGC-1\\u03b1, PGC-1\\u03b2, PRC) that bind NRF-1 directly, integrating it into the program of mitochondrial biogenesis [#8, #17, #34]; serum-stimulated phosphorylation enhances its transactivation and respiratory output [#9]. The protein heterodimerizes with small Maf proteins (MafG/MafK), which increase its affinity for NF-E2/ARE sites yet can repress its transactivation, enabling combinatorial control of antioxidant and target genes such as the glutathione-synthesis gene GCS-h [#4, #6, #12]. As a proteostatic regulator, NFE2L1 is synthesized into the ER membrane and constitutively targeted to ERAD, then retrotranslocated by p97, deglycosylated, and proteolytically processed by DDI-1/2 to generate active nuclear isoforms; upon proteasome inhibition it accumulates in the nucleus and binds AREs in proteasome subunit gene promoters to mount the proteasome bounce-back response [#20, #23, #30]. This non-canonical activation is restrained by SCFFBS2\\u2013ARIH1, which ubiquitinates NFE2L1 through oxyester bonds on N-GlcNAc residues to block DDI2-mediated processing [#29]. Beyond proteasome subunits, NFE2L1 couples this response to aggrephagy by inducing p62/SQSTM1 and GABARAPL1 [#28] and protects against ferroptosis by sustaining GPX4 expression and proteasomal activity [#25, #26]. Isoform-specific control is intrinsic to the locus: long isoforms (TCF11) act as transcriptional activators, while the short LCR-F1 isoform lacks transactivation domains and behaves as a dominant-negative inhibitor [#13]. Genetic studies establish essential physiological roles, with Nfe2l1 loss causing gastrulation failure and defective definitive erythropoiesis in mice and tissue-specific phenotypes in adipose, bone, and muscle [#5, #7, #32, #33].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Established NRF-1 as a single trans-acting factor coordinating multiple nuclear-encoded respiratory genes, defining its core role in mitochondrial gene expression.\",\n      \"evidence\": \"DNA competition binding, chromatographic copurification, methylation interference footprinting, and in vivo transfection across cytochrome c, COX VIc, reductase, and MRP RNA genes\",\n      \"pmids\": [\"2547796\", \"2166701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify coactivators or upstream signals\", \"Protein identity not yet cloned\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Cloning and domain mapping defined NRF-1 as a new class of DNA-binding protein and localized its DNA-binding activity to the N-terminal half, enabling molecular dissection.\",\n      \"evidence\": \"cDNA cloning from HeLa tryptic peptides, deletion mapping, recombinant protein, supershift\",\n      \"pmids\": [\"8253388\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transactivation domain architecture not yet mapped\", \"Regulation of activity unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed NFE2L1 partners with small Maf proteins at NF-E2/ARE sites and that dimer composition tunes both DNA affinity and transactivation, revealing combinatorial regulation.\",\n      \"evidence\": \"In vitro heterodimerization, EMSA/supershift, SELEX, and reporter assays with MafG\",\n      \"pmids\": [\"8932385\", \"9421508\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular context determining activation versus repression unclear\", \"ARE target gene repertoire not defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Knockout mice established NFE2L1 as developmentally essential, required non-cell-autonomously for gastrulation and definitive erythropoiesis.\",\n      \"evidence\": \"Gene targeting, blastocyst chimeras, and developmental/hematological phenotyping in mice\",\n      \"pmids\": [\"9087432\", \"9501099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The signaling molecules mediating the non-cell-autonomous effect not identified\", \"Direct target genes underlying the phenotype unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined isoform-based regulation: full-length TCF11 carries two transactivation domains while the short LCR-F1 isoform is a dominant-negative inhibitor.\",\n      \"evidence\": \"Domain deletion/swap mutants and reporter assays across cell lines; antioxidant GCS-h promoter activation via ARE\",\n      \"pmids\": [\"11278371\", \"11342101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological balance of isoforms in tissues not measured\", \"Mechanism of dominant-negative action not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked NRF-1 to the PGC-1/PRC coactivator program and the mitochondrial transcription machinery, positioning it as an integrator of biogenesis signals.\",\n      \"evidence\": \"NRF-1 site mutagenesis in Tfam/TFB1M/TFB2M promoters, ectopic PGC-1\\u03b1 expression, reciprocal Co-IP, ChIP, and respiratory growth assays for PRC; serum-induced phosphorylation\",\n      \"pmids\": [\"15684387\", \"16908542\", \"10777619\", \"20561910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinases phosphorylating NRF-1 not identified\", \"Structural basis of coactivator binding unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified physical partners beyond transcription, including dynein light chain and a PARP-1\\u00b7DNA-PK\\u00b7Ku\\u00b7topoisomerase II\\u03b2 complex that NRF-1 can recruit and that PARylates its DNA-binding domain.\",\n      \"evidence\": \"Yeast two-hybrid, crosslinking of purified proteins, Co-IP, domain mapping, PARylation assay, and ChIP\",\n      \"pmids\": [\"11069771\", \"19181665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of dynein interaction for NRF-1 trafficking unclear\", \"Genome-wide impact of PARP-1 recruitment not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed NFE2L1 as the transcription factor driving the proteasome bounce-back response, controlled by ER residence and ERAD requiring HRD1 and p97.\",\n      \"evidence\": \"Cell-based factor identification, subcellular fractionation, dominant-negative ERAD components, and promoter-binding assays after proteasome inhibition\",\n      \"pmids\": [\"20932482\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease generating the active form not yet identified\", \"Retrotranslocation-to-nucleus steps not fully ordered\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the sequential post-translational processing pathway converting ER-bound glycoprotein NFE2L1 into active nuclear isoforms via p97 retrotranslocation, deglycosylation, and DDI-1/2 cleavage.\",\n      \"evidence\": \"Mutagenesis, glycosylation/deglycosylation assays, p97/ERAD and proteasome inhibitors, isoform western blots\",\n      \"pmids\": [\"30287392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative feedback dynamics not modeled\", \"Glycosidase identities incompletely defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended NFE2L1's proteostatic output to selective autophagy and demonstrated therapeutic gain-of-function, coupling the bounce-back response to aggrephagy and neuroprotection.\",\n      \"evidence\": \"RNA-seq, knockdown, immunofluorescence of p62/ULK1/TBK1 puncta and Ser403 phosphorylation; AAV overexpression in mouse retina with proteasome and survival readouts\",\n      \"pmids\": [\"37658135\", \"37450596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect induction of autophagy genes not fully separated\", \"Durability of neuroprotective effect not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established NFE2L1 as a ferroptosis-resistance factor acting through GPX4 maintenance and proteasomal capacity, distinct from NFE2L2.\",\n      \"evidence\": \"Gene knockout cell and mouse models (Gpx4-KO, Nfe2l1-deficient), ferroptosis induction, GPX4 and proteasome activity assays, patient-derived cells\",\n      \"pmids\": [\"35271393\", \"34999280\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GPX4 is a direct transcriptional target not resolved\", \"Tissue specificity of ferroptosis protection incompletely mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined the non-canonical ubiquitin switch and proteolytic activation controlling NFE2L1: SCFFBS2\\u2013ARIH1 ubiquitinates N-GlcNAc residues to block activation, while DDI2 cleavage activates the factor during ferroptosis-induced proteasome stress.\",\n      \"evidence\": \"In vitro reconstitution on glycopeptides, E3/UBE2L3 identification, mass spectrometry, DDI2 knockout, proteomic ubiquitylation mapping, nelfinavir inhibition\",\n      \"pmids\": [\"39116872\", \"39384955\", \"32344880\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatial coordination of ENGASE/ARIH1/DDI2 steps not defined\", \"Physiological triggers tuning this switch incompletely characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NFE2L1 integrates its mitochondrial-biogenesis and proteostasis programs within a single cell, and how isoform balance and metabolic sensing (e.g., AMPK inhibition) are coordinated in vivo, remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking respiratory-gene activation and proteasome bounce-back\", \"Direct AMPK-inhibition mechanism rests on single-lab Co-IP\", \"In vivo determinants of isoform choice unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 3, 19]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 13, 20]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [20, 23]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 20]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 20]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [20, 23, 28, 29]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [20, 25, 26]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [8, 17, 34]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MafG\", \"MafK\", \"PRC\", \"PGC-1\\u03b1\", \"PGC-1\\u03b2\", \"PARP-1\", \"AMPK\", \"DDI2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}